102 Zelniker Zelniker TA TA Wiviott Wiviott SD SD Raz Raz I I Im Im K K Goodrich Goodrich EL EL Bonaca Bonaca MP MP SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Lancet Lancet 2019 2019 393 393 10166 10166 31 31 39 39 30424892 30424892 102. Here, SLC5A2 is linked to type 2 diabetes mellitus.